82 related articles for article (PubMed ID: 10374318)
21. Mutant p53-induced immortalization of primary human mammary epithelial cells.
Gao Q; Hauser SH; Liu XL; Wazer DE; Madoc-Jones H; Band V
Cancer Res; 1996 Jul; 56(13):3129-33. PubMed ID: 8674072
[TBL] [Abstract][Full Text] [Related]
22. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
[TBL] [Abstract][Full Text] [Related]
23. Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein.
Gudas JM; Nguyen H; Li T; Sadzewicz L; Robey R; Wosikowski K; Cowan KH
Carcinogenesis; 1996 Jul; 17(7):1417-27. PubMed ID: 8706243
[TBL] [Abstract][Full Text] [Related]
24. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.
Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ
Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022
[TBL] [Abstract][Full Text] [Related]
25. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
[TBL] [Abstract][Full Text] [Related]
26. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
[TBL] [Abstract][Full Text] [Related]
27. P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression.
Kouvidou C; Stefanaki K; Dai Y; Tzardi M; Koutsoubi K; Darivianaki K; Karidi E; Rontogianni D; Zois E; Kakolyris S; Georgoulias V; Delides G; Kanavaros P
Anticancer Res; 1997; 17(4A):2615-9. PubMed ID: 9252690
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of p53 and p21WAF1/CIP1 sensitizes human breast cancer cells to paclitaxel and its combination with 5-fluorouracil.
Johnson KR; Fan W
Anticancer Res; 2002; 22(6A):3197-204. PubMed ID: 12530065
[TBL] [Abstract][Full Text] [Related]
29. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
30. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P
J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in astrocytic gliomas and their correlation to cell proliferation.
Dietzmann K; von Bossanyi P; Sallaba J; Kirches E; Synowitz HJ; Warich-Kirches M
Gen Diagn Pathol; 1996 May; 141(5-6):339-44. PubMed ID: 8780933
[TBL] [Abstract][Full Text] [Related]
32. Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways.
Nieves-Neira W; Pommier Y
Int J Cancer; 1999 Jul; 82(3):396-404. PubMed ID: 10399957
[TBL] [Abstract][Full Text] [Related]
33. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM
Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism of growth inhibition by genistein of human breast carcinoma].
Shao Z; Shen Z
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):325-8. PubMed ID: 11776565
[TBL] [Abstract][Full Text] [Related]
35. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
Parker LP; Wolf JK; Price JE
Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas.
Valassiadou KE; Stefanaki K; Tzardi M; Datseris G; Georgoulias V; Melissas J; Tsiftsis DD; Delides G; Kanavaros P
Anticancer Res; 1997; 17(4A):2571-6. PubMed ID: 9252682
[TBL] [Abstract][Full Text] [Related]
37. Low-dose irradiation promotes proliferation of the human breast cancer MDA-MB-231 cells through accumulation of mutant P53.
Li SJ; Liang XY; Li HJ; Li W; Zhou L; Chen HQ; Ye SG; Yu DH; Cui JW
Int J Oncol; 2017 Jan; 50(1):290-296. PubMed ID: 27959407
[TBL] [Abstract][Full Text] [Related]
38. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
40. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
